Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjects.

With an aim to assess the pharmacokinetics of atovaquone, 10 healthy subjects were administered Malarone® alone and in combination with ketoconazole in a crossover study. The results indicated 68% higher Cmax, 74% higher AUC and 34% lower CL/F of atovaquone following co-administration with ketoconaz...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Travel Medicine Vol. 29; no. 4; pp. 1 - 5
Autores principales: Thapar, Mita M, Ursing, Johan, Ashton, Michael, Bergqvist, Yngve, Gil, José Pedro, Björkman, Anders
Formato: Journal Article
Publicado: Oxford University Press / USA May2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158041453&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 158041453
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        11951982
        9O9
      jtl: Journal of Travel Medicine
      issn: 11951982
      maglogo: N
    pubinfo:
      dt: May2022
      vid: 29
      iid: 4
      pid: 10398
      pub: Oxford University Press / USA
    artinfo:
      ui:
        158041453
        158041453
        NLM35532299
        10.1093/jtm/taac058
        NLM35532299
        158041453
      ppf: 1
      ppct: 4
      formats:
      tig:
        atl: Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjects.
      aug:
        au:
          Thapar, Mita M
          Ursing, Johan
          Ashton, Michael
          Bergqvist, Yngve
          Gil, José Pedro
          Björkman, Anders
        affil: Principal PK Scientist , Quantitative Pharmacology & Pharmacometrics, Early Phase Services, ICON Clinical Research, Reading, UK
      sug:
        subj:
          Antimalarials Adverse Effects
          Malaria Drug Therapy
          Chloroguanide Adverse Effects
          Drug Combinations
          Research Subjects
          Ketoconazole Adverse Effects
          Atovaquone Adverse Effects
      ab: With an aim to assess the pharmacokinetics of atovaquone, 10 healthy subjects were administered Malarone® alone and in combination with ketoconazole in a crossover study. The results indicated 68% higher Cmax, 74% higher AUC and 34% lower CL/F of atovaquone following co-administration with ketoconazole compared to administration of atovaquone alone.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N